4-Amino-3-(trifluoromethoxy)benzoic acid | CAS:175278-22-5

We serve 4-Amino-3-(trifluoromethoxy)benzoic acid CAS:175278-22-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Amino-3-(trifluoromethoxy)benzoic acid

Chemical Name:4-Amino-3-(trifluoromethoxy)benzoic acid
CAS.NO:175278-22-5
Synonyms:4-Amino-3-trifluoromethoxy benzoic acid;
Molecular Formula:C8H6F3NO3
Molecular Weight:221.13300
 
Physical and Chemical Properties:
Density:1.528;
Melting point:168-169oC;
Boiling point:303.2oC;
Flash point:137.2oC;
Index of Refraction:1.498;
 
Specification:
Appearance:White solid
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 4-Amino-3-(trifluoromethoxy)benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Amino-3-trifluoromethoxy benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Amino-3-trifluoromethoxy benzoic acid Use and application,4-Amino-3-trifluoromethoxy benzoic acid technical grade,usp/ep/jp grade.


Related News: The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.N-(2-Butylbenzofuran-5-yl)methanesulfonamide manufacturer A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday.Methyltriethoxysilane supplier A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday.2-Cyano-6-methylpyridine vendor U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.